Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.
Catherine J Mummery,Anne Börjesson-Hanson,Daniel J Blackburn,Everard G B Vijverberg,Peter Paul De Deyn,Simon Ducharme,Michael Jonsson, Anja Schneider,Juha O Rinne,Albert C Ludolph, Ralf Bodenschatz,Holly Kordasiewicz,Eric E Swayze,Bethany Fitzsimmons,Laurence Mignon, Katrina M Moore,Chris Yun, Tiffany Baumann, Dan Li,Daniel A Norris,Rebecca Crean, Danielle L Graham, Ellen Huang, Elena Ratti,C Frank Bennett, Candice Junge,Roger M Lane Nature medicine(2024)
AI 理解论文
溯源树
样例